Mark E. Andracki

507 total citations
15 papers, 408 citations indexed

About

Mark E. Andracki is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Mark E. Andracki has authored 15 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cell Biology. Recurrent topics in Mark E. Andracki's work include Hemoglobin structure and function (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). Mark E. Andracki is often cited by papers focused on Hemoglobin structure and function (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). Mark E. Andracki collaborates with scholars based in United States. Mark E. Andracki's co-authors include Stephen K. Hunter, Joseph A. Walder, Roxanne Y. Walder, Arthur Μ. Krieg, John M. Dagle, Donna A. Santillan, Jean-Marc Lalouel, Stephen G. Sligar, Ituro Inoue and Jheem D. Medh and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mark E. Andracki

15 papers receiving 395 citations

Peers

Mark E. Andracki

ONCOL

SURGE

Ann‐Charlotte Bergman Sweden

Ernest C. Adams United States

Anastasia Liapis United States

R. B. de Zanger United States

Araceli Valverde United States

Fabienne Proamer France

Min Guan China

Malin Bern Norway

Basil Hanss United States

Evelyne Crabbé Belgium

Ann‐Charlotte Bergman Sweden

Mark E. Andracki

321 ×2.0

126 ×1.6

85 ×1.3

ONCOL

44 ×0.8

SURGE

32 ×0.6

Citations per year, relative to Mark E. Andracki Mark E. Andracki (= 1×) peers Ann‐Charlotte Bergman

Countries citing papers authored by Mark E. Andracki

Since Specialization

Citations

This map shows the geographic impact of Mark E. Andracki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Andracki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Andracki more than expected).

Fields of papers citing papers by Mark E. Andracki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Andracki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Andracki. The network helps show where Mark E. Andracki may publish in the future.

Co-authorship network of co-authors of Mark E. Andracki

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Andracki. A scholar is included among the top collaborators of Mark E. Andracki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Andracki. Mark E. Andracki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kikuchi, Ryota, Yanbin Lao, Daniel A.J. Bow, et al.. (2013). Prediction of Clinical Drug–Drug Interactions of Veliparib (ABT-888) with Human Renal Transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K). Journal of Pharmaceutical Sciences. 102(12). 4426–4432. 51 indexed citations

Liguori, Michael J., Hong Liu, Rita Ciurlionis, et al.. (2012). AhR activation underlies the CYP1A autoinduction by A-998679 in rats. Frontiers in Genetics. 3. 213–213. 7 indexed citations

Santillan, Donna A., Mark E. Andracki, & Stephen K. Hunter. (2007). Protective immunization in mice against group B streptococci using encapsulated C5a peptidase. American Journal of Obstetrics and Gynecology. 198(1). 114.e1–114.e6. 30 indexed citations

Yang, Baoli, et al.. (2007). Can Myoglobin Expression in Pancreatic Beta Cells Improve Insulin Secretion Under Hypoxia? An Exploratory Study With Transgenic Porcine Islets. Artificial Organs. 31(7). 521–531. 3 indexed citations

Hunter, Stephen K., et al.. (2006). Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices. Biomaterials. 28(1). 89–98. 28 indexed citations

Zaharias, Rebecca, et al.. (2005). Rotary Culture Enhances Pre-osteoblast Aggregation and Mineralization. Journal of Dental Research. 84(6). 542–547. 40 indexed citations

Hunter, Stephen K., Mark E. Andracki, & Arthur Μ. Krieg. (2001). Biodegradable microspheres containing group B Streptococcus vaccine: Immune response in mice. American Journal of Obstetrics and Gynecology. 185(5). 1174–1179. 36 indexed citations

Medh, Jheem D., Glenna L. Fry, Mark E. Andracki, et al.. (1996). Lipoprotein Lipase Binds to Low Density Lipoprotein Receptors and Induces Receptor-mediated Catabolism of Very Low Density Lipoproteins. Journal of Biological Chemistry. 271(29). 17073–17080. 72 indexed citations

Andracki, Mark E., et al.. (1994). Prolongation of the Intravascular Retention of Hemoglobin Modified with a Long-Chain Fatty Acid Derivative. Artificial Cells Blood Substitutes and Biotechnology. 22(1). 27–42. 3 indexed citations

10.

Walder, Roxanne Y., Mark E. Andracki, & Joseph A. Walder. (1994). [17] Preparation of intramolecularly cross-linked hemoglobins. Methods in enzymology on CD-ROM/Methods in enzymology. 231. 274–280. 28 indexed citations

11.

Jiang, Jie, et al.. (1993). Allosteric kinetics and equilibria of triligated, cross-linked hemoglobin. Biophysical Journal. 64(5). 1520–1532. 4 indexed citations

12.

Andracki, Mark E., et al.. (1992). Human hemoglobin expression in Escherichia coli: importance of optimal codon usage. Biochemistry. 31(36). 8619–8628. 55 indexed citations

13.

Dagle, John M., et al.. (1991). Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages. Nucleic Acids Research. 19(8). 1805–1810. 43 indexed citations

14.

Andracki, Mark E., et al.. (1988). Acylation of subtilisin A by aryl esters: contribution to rate limitation by a physical step preceding general acid-base catalysis. Biochemistry. 27(21). 8000–8007. 4 indexed citations

15.

Andracki, Mark E., et al.. (1985). Rate-controlling step of oxazolinone formation. Secondary and solvent kinetic isotope effects. Journal of the American Chemical Society. 107(21). 6036–6039. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact